Novartis Pharma

Pharmaceutical company of the Novartis group, with its head office at Basel in Switzerland, formed in 1996 by the merger of Ciba-Geigy and Sandoz and now focused wholly on innovative medicines after the generics and eye care businesses were separated. Discovers, develops, makes and sells prescription medicines in cardiovascular and metabolic disease, immunology, neuroscience, oncology and haematology, including cell and gene therapies and radioligand therapies, and runs its own research institutes, non-clinical safety and toxicology laboratories and clinical development worldwide.